Janus Henderson Group’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.18M | Hold |
|
|||||
|
2025
Q2 | $1.2M | Sell |
|
|||||
|
2025
Q1 | $1.07M | Hold |
|
|||||
|
2024
Q4 | $873K | Sell |
|
|||||
|
2024
Q3 | $49.9M | Sell |
|
|||||
|
2024
Q2 | $46.6M | Sell |
|
|||||
|
2024
Q1 | $56.3M | Sell |
|
|||||
|
2023
Q4 | $53.4M | Sell |
|
|||||
|
2023
Q3 | $60.7M | Sell |
|
|||||
|
2023
Q2 | $69.9M | Sell |
|
|||||
|
2023
Q1 | $92.4M | Sell |
|
|||||
|
2022
Q4 | $103M | Sell |
|
|||||
|
2022
Q3 | $222M | Buy |
|
|||||
|
2022
Q2 | $131M | Buy |
|
|||||
|
2022
Q1 | $108M | Buy |
|
|||||
|
2021
Q4 | $102M | Buy |
|
|||||
|
2021
Q3 | $85.4M | Sell |
|
|||||
|
2021
Q2 | $154M | Buy |
|
|||||
|
2021
Q1 | $54.1M | Sell |
|
|||||
|
2020
Q4 | $245M | Buy |
|
|||||
|
2020
Q3 | $199M | Buy |
|
|||||
|
2020
Q2 | $219M | Buy |
|